Identification of candidate cardiomyopathy modifier genes through genome sequencing and RNA profiling

Evaluation of the whole genome, even in the case of alleged monogenic disease, leads to important new insights. The identified variants, regions, and genes are candidates to modify disease presentation in cardiomyopathy.